Loading…
2MO Expression levels of immune checkpoint markers (IC) in hormone receptor-positive/HER2-negative (HR+/HER2-) metastatic breast cancer (BC)
Saved in:
| Published in: | ESMO open 2023-05, Vol.8 (1), p.101226, Article 101226 |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , |
| Format: | Article |
| Language: | English |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| cited_by | |
|---|---|
| cites | |
| container_end_page | |
| container_issue | 1 |
| container_start_page | 101226 |
| container_title | ESMO open |
| container_volume | 8 |
| creator | Pabba, A. Zels, G. De Schepper, M. Geukens, T. Van Baelen, K. Maetens, M. Nguyen, H.L. Mahdami, A. Boeckx, B. Vanderheyden, E. Punie, K. Neven, P. Wildiers, H. Van Den Bogaert, W. Biganzoli, E. Lambrechts, D. Floris, G. Richard, F. Desmedt, C. |
| description | |
| doi_str_mv | 10.1016/j.esmoop.2023.101226 |
| format | article |
| fullrecord | <record><control><sourceid>elsevier_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1016_j_esmoop_2023_101226</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S2059702923004520</els_id><sourcerecordid>S2059702923004520</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1466-d3bdcc611cfc5c490bdaab3e53d92e3ff6d578f799a1684a1ea5a290acc4bdcf3</originalsourceid><addsrcrecordid>eNp9kMFKAzEQhoMoWGrfwEOOLbJtkt3Ndi-ClmoLlULRc8hmJzZtd7Mka9F38KHNsh48eZp_fuYfZj6EbimZUkL57DAFX1nbTBlhcWcxxi_QgJE0jzLC8ss_-hqNvD8QQmiWBJMP0Dd72eLlZ-PAe2NrfIIznDy2Gpuq-qgBqz2oY2NN3eJKuiM4j8frxQSbGu-tq2wYcaCgaa2LGutNa84wWy13LKrhXXYdHq92d701wRW00rfBV7hwECRWslbg8PhxMblBV1qePIx-6xC9PS1fF6tos31eLx42kaIJ51EZF6VSnFKlVaqSnBSllEUMaVzmDGKteZlmc53luaR8nkgKMpUsJ1KpJCR1PERJv1c5670DLRpnwndfghLRQRUH0UMVHVTRQw2x-z4WCMHZgBNeGQjXlyYgaEVpzf8LfgAnWYLk</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>2MO Expression levels of immune checkpoint markers (IC) in hormone receptor-positive/HER2-negative (HR+/HER2-) metastatic breast cancer (BC)</title><source>Elsevier ScienceDirect Journals</source><source>PubMed Central</source><creator>Pabba, A. ; Zels, G. ; De Schepper, M. ; Geukens, T. ; Van Baelen, K. ; Maetens, M. ; Nguyen, H.L. ; Mahdami, A. ; Boeckx, B. ; Vanderheyden, E. ; Punie, K. ; Neven, P. ; Wildiers, H. ; Van Den Bogaert, W. ; Biganzoli, E. ; Lambrechts, D. ; Floris, G. ; Richard, F. ; Desmedt, C.</creator><creatorcontrib>Pabba, A. ; Zels, G. ; De Schepper, M. ; Geukens, T. ; Van Baelen, K. ; Maetens, M. ; Nguyen, H.L. ; Mahdami, A. ; Boeckx, B. ; Vanderheyden, E. ; Punie, K. ; Neven, P. ; Wildiers, H. ; Van Den Bogaert, W. ; Biganzoli, E. ; Lambrechts, D. ; Floris, G. ; Richard, F. ; Desmedt, C.</creatorcontrib><identifier>ISSN: 2059-7029</identifier><identifier>EISSN: 2059-7029</identifier><identifier>DOI: 10.1016/j.esmoop.2023.101226</identifier><language>eng</language><publisher>Elsevier Ltd</publisher><ispartof>ESMO open, 2023-05, Vol.8 (1), p.101226, Article 101226</ispartof><rights>2023</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S2059702923004520$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,778,782,3538,27907,27908,45763</link.rule.ids></links><search><creatorcontrib>Pabba, A.</creatorcontrib><creatorcontrib>Zels, G.</creatorcontrib><creatorcontrib>De Schepper, M.</creatorcontrib><creatorcontrib>Geukens, T.</creatorcontrib><creatorcontrib>Van Baelen, K.</creatorcontrib><creatorcontrib>Maetens, M.</creatorcontrib><creatorcontrib>Nguyen, H.L.</creatorcontrib><creatorcontrib>Mahdami, A.</creatorcontrib><creatorcontrib>Boeckx, B.</creatorcontrib><creatorcontrib>Vanderheyden, E.</creatorcontrib><creatorcontrib>Punie, K.</creatorcontrib><creatorcontrib>Neven, P.</creatorcontrib><creatorcontrib>Wildiers, H.</creatorcontrib><creatorcontrib>Van Den Bogaert, W.</creatorcontrib><creatorcontrib>Biganzoli, E.</creatorcontrib><creatorcontrib>Lambrechts, D.</creatorcontrib><creatorcontrib>Floris, G.</creatorcontrib><creatorcontrib>Richard, F.</creatorcontrib><creatorcontrib>Desmedt, C.</creatorcontrib><title>2MO Expression levels of immune checkpoint markers (IC) in hormone receptor-positive/HER2-negative (HR+/HER2-) metastatic breast cancer (BC)</title><title>ESMO open</title><issn>2059-7029</issn><issn>2059-7029</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNp9kMFKAzEQhoMoWGrfwEOOLbJtkt3Ndi-ClmoLlULRc8hmJzZtd7Mka9F38KHNsh48eZp_fuYfZj6EbimZUkL57DAFX1nbTBlhcWcxxi_QgJE0jzLC8ss_-hqNvD8QQmiWBJMP0Dd72eLlZ-PAe2NrfIIznDy2Gpuq-qgBqz2oY2NN3eJKuiM4j8frxQSbGu-tq2wYcaCgaa2LGutNa84wWy13LKrhXXYdHq92d701wRW00rfBV7hwECRWslbg8PhxMblBV1qePIx-6xC9PS1fF6tos31eLx42kaIJ51EZF6VSnFKlVaqSnBSllEUMaVzmDGKteZlmc53luaR8nkgKMpUsJ1KpJCR1PERJv1c5670DLRpnwndfghLRQRUH0UMVHVTRQw2x-z4WCMHZgBNeGQjXlyYgaEVpzf8LfgAnWYLk</recordid><startdate>202305</startdate><enddate>202305</enddate><creator>Pabba, A.</creator><creator>Zels, G.</creator><creator>De Schepper, M.</creator><creator>Geukens, T.</creator><creator>Van Baelen, K.</creator><creator>Maetens, M.</creator><creator>Nguyen, H.L.</creator><creator>Mahdami, A.</creator><creator>Boeckx, B.</creator><creator>Vanderheyden, E.</creator><creator>Punie, K.</creator><creator>Neven, P.</creator><creator>Wildiers, H.</creator><creator>Van Den Bogaert, W.</creator><creator>Biganzoli, E.</creator><creator>Lambrechts, D.</creator><creator>Floris, G.</creator><creator>Richard, F.</creator><creator>Desmedt, C.</creator><general>Elsevier Ltd</general><scope>6I.</scope><scope>AAFTH</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>202305</creationdate><title>2MO Expression levels of immune checkpoint markers (IC) in hormone receptor-positive/HER2-negative (HR+/HER2-) metastatic breast cancer (BC)</title><author>Pabba, A. ; Zels, G. ; De Schepper, M. ; Geukens, T. ; Van Baelen, K. ; Maetens, M. ; Nguyen, H.L. ; Mahdami, A. ; Boeckx, B. ; Vanderheyden, E. ; Punie, K. ; Neven, P. ; Wildiers, H. ; Van Den Bogaert, W. ; Biganzoli, E. ; Lambrechts, D. ; Floris, G. ; Richard, F. ; Desmedt, C.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1466-d3bdcc611cfc5c490bdaab3e53d92e3ff6d578f799a1684a1ea5a290acc4bdcf3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Pabba, A.</creatorcontrib><creatorcontrib>Zels, G.</creatorcontrib><creatorcontrib>De Schepper, M.</creatorcontrib><creatorcontrib>Geukens, T.</creatorcontrib><creatorcontrib>Van Baelen, K.</creatorcontrib><creatorcontrib>Maetens, M.</creatorcontrib><creatorcontrib>Nguyen, H.L.</creatorcontrib><creatorcontrib>Mahdami, A.</creatorcontrib><creatorcontrib>Boeckx, B.</creatorcontrib><creatorcontrib>Vanderheyden, E.</creatorcontrib><creatorcontrib>Punie, K.</creatorcontrib><creatorcontrib>Neven, P.</creatorcontrib><creatorcontrib>Wildiers, H.</creatorcontrib><creatorcontrib>Van Den Bogaert, W.</creatorcontrib><creatorcontrib>Biganzoli, E.</creatorcontrib><creatorcontrib>Lambrechts, D.</creatorcontrib><creatorcontrib>Floris, G.</creatorcontrib><creatorcontrib>Richard, F.</creatorcontrib><creatorcontrib>Desmedt, C.</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>CrossRef</collection><jtitle>ESMO open</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Pabba, A.</au><au>Zels, G.</au><au>De Schepper, M.</au><au>Geukens, T.</au><au>Van Baelen, K.</au><au>Maetens, M.</au><au>Nguyen, H.L.</au><au>Mahdami, A.</au><au>Boeckx, B.</au><au>Vanderheyden, E.</au><au>Punie, K.</au><au>Neven, P.</au><au>Wildiers, H.</au><au>Van Den Bogaert, W.</au><au>Biganzoli, E.</au><au>Lambrechts, D.</au><au>Floris, G.</au><au>Richard, F.</au><au>Desmedt, C.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>2MO Expression levels of immune checkpoint markers (IC) in hormone receptor-positive/HER2-negative (HR+/HER2-) metastatic breast cancer (BC)</atitle><jtitle>ESMO open</jtitle><date>2023-05</date><risdate>2023</risdate><volume>8</volume><issue>1</issue><spage>101226</spage><pages>101226-</pages><artnum>101226</artnum><issn>2059-7029</issn><eissn>2059-7029</eissn><pub>Elsevier Ltd</pub><doi>10.1016/j.esmoop.2023.101226</doi><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 2059-7029 |
| ispartof | ESMO open, 2023-05, Vol.8 (1), p.101226, Article 101226 |
| issn | 2059-7029 2059-7029 |
| language | eng |
| recordid | cdi_crossref_primary_10_1016_j_esmoop_2023_101226 |
| source | Elsevier ScienceDirect Journals; PubMed Central |
| title | 2MO Expression levels of immune checkpoint markers (IC) in hormone receptor-positive/HER2-negative (HR+/HER2-) metastatic breast cancer (BC) |
| url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-16T22%3A28%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-elsevier_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=2MO%20Expression%20levels%20of%20immune%20checkpoint%20markers%20(IC)%20in%20hormone%20receptor-positive/HER2-negative%20(HR+/HER2-)%20metastatic%20breast%20cancer%20(BC)&rft.jtitle=ESMO%20open&rft.au=Pabba,%20A.&rft.date=2023-05&rft.volume=8&rft.issue=1&rft.spage=101226&rft.pages=101226-&rft.artnum=101226&rft.issn=2059-7029&rft.eissn=2059-7029&rft_id=info:doi/10.1016/j.esmoop.2023.101226&rft_dat=%3Celsevier_cross%3ES2059702923004520%3C/elsevier_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c1466-d3bdcc611cfc5c490bdaab3e53d92e3ff6d578f799a1684a1ea5a290acc4bdcf3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |